| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| BAUR MICHAEL L | CEO, President, BOD Chair, Director | 6 LOGUE COURT, GREENVILLE | J. Creighton Lynes, attorney-in-fact | 2025-09-19 | 0001251456 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | SCSC | Common Stock | Options Exercise | $3.9M | +102K | +44.85% | $38.19 | 330K | Sep 17, 2025 | Direct | |
| transaction | SCSC | Common Stock | Sale | -$4.59M | -102K | -30.96% | $44.96 | 228K | Sep 17, 2025 | Direct | F1 |
| transaction | SCSC | Common Stock | Options Exercise | $877K | +23K | +10.1% | $38.19 | 250K | Sep 18, 2025 | Direct | |
| transaction | SCSC | Common Stock | Sale | -$2.13M | -48K | -19.15% | $44.34 | 203K | Sep 18, 2025 | Direct | F2 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | SCSC | Employee Stock Option (Right to Buy) | Options Exercise | $0 | -102K | -81.62% | $0.00 | 23K | Sep 17, 2025 | Common Stock | 102K | $38.19 | Direct | F3 |
| transaction | SCSC | Employee Stock Option (Right to Buy) | Options Exercise | $0 | -23K | -100% | $0.00 | 0 | Sep 18, 2025 | Common Stock | 23K | $38.19 | Direct | F3 |
| Id | Content |
|---|---|
| F1 | The price reported in column 4 is the weighed average price. These shares were sold in multiple transactions at prices ranging from $44.25 to $45.23 inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F2 | The price reported in column 4 is the weighed average price. These shares were sold in multiple transactions at prices ranging from $44.15 to $44.66 inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F3 | The option vested in one-third increments on the anniversary of the grant date on 12/4/2016, 12/4/2017 and 12/4/2018. |